Erythrodermic Psoriasis Managed with Risankizumab
Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortality rate associated with EP and other causes of erythroderma, they are often classified as dermatologic emergencies. EP is usually a therapeutic challenge, where topical and conventi...
| Published in: | Case Reports in Dermatology |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2022-08-01
|
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/525774 |